HBXIP regulates VEGFA expression and angiogenesis in breast cancer cells by inhibiting miR-503 expression as well as by hyperactivating PI3K/Akt-mediated HIF1α signaling (85). The gene discussed is HIF1A; the disease is breast carcinoma.